Copper at synapse: Release, binding and modulation of neurotransmission
N D'Ambrosi, L Rossi - Neurochemistry international, 2015 - Elsevier
Over the last decade, a piece of the research studying copper role in biological systems was
devoted to unravelling a still elusive, but extremely intriguing, aspect that is the involvement …
devoted to unravelling a still elusive, but extremely intriguing, aspect that is the involvement …
Insights on the interaction of alpha-synuclein and metals in the pathophysiology of Parkinson's disease
E Carboni, P Lingor - Metallomics, 2015 - academic.oup.com
Parkinson's disease (PD) is the most frequent neurodegenerative movement disorder with
severe consequences for patients and caregivers. In the last twenty years of research, alpha …
severe consequences for patients and caregivers. In the last twenty years of research, alpha …
The role of copper ions in pathophysiology and fluorescent sensors for the detection thereof
P Verwilst, K Sunwoo, JS Kim - Chemical Communications, 2015 - pubs.rsc.org
Copper ions are indispensible to life and maintaining tight control over the homeostasis of
copper ions in the body is a prerequisite to sustaining health. Aberrations in normal copper …
copper ions in the body is a prerequisite to sustaining health. Aberrations in normal copper …
Control of protein orientation on gold nanoparticles
Gold nanoparticles (Au NPs) have attracted much attention due to their potential
applications in nanomedicine. While numerous studies have quantified biomolecular …
applications in nanomedicine. While numerous studies have quantified biomolecular …
Copper binding to the N-terminally acetylated, naturally occurring form of alpha-synuclein induces local helical folding
MC Miotto, AA Valiente-Gabioud… - Journal of the …, 2015 - ACS Publications
Growing evidence supports a link between brain copper homeostasis, the formation of alpha-
synuclein (AS)-copper complexes, and the development of Parkinson disease (PD) …
synuclein (AS)-copper complexes, and the development of Parkinson disease (PD) …
Overexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathways
A Anandhan, H Rodriguez-Rocha, I Bohovych… - Neurobiology of …, 2015 - Elsevier
Gene multiplications or point mutations in alpha (α)-synuclein are associated with familial
and sporadic Parkinson's disease (PD). An increase in copper (Cu) levels has been …
and sporadic Parkinson's disease (PD). An increase in copper (Cu) levels has been …
Reactivity of copper–α-synuclein peptide complexes relevant to Parkinson's disease
S Dell'Acqua, V Pirota, C Anzani, MM Rocco… - Metallomics, 2015 - academic.oup.com
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the presence of
abnormal α-synuclein (αSyn) deposits in the brain. Alterations in metal homeostasis and …
abnormal α-synuclein (αSyn) deposits in the brain. Alterations in metal homeostasis and …
Remote His50 acts as a coordination switch in the high-affinity N-terminal centered copper (II) site of α-synuclein
R De Ricco, D Valensin, S Dell'Acqua… - Inorganic …, 2015 - ACS Publications
Parkinson's disease (PD) etiology is closely linked to the aggregation of α-synuclein (αS).
Copper (II) ions can bind to αS and may impact its aggregation propensity. As a …
Copper (II) ions can bind to αS and may impact its aggregation propensity. As a …
Differences in the binding of copper (I) to α-and β-synuclein
R De Ricco, D Valensin, S Dell'Acqua… - Inorganic …, 2015 - ACS Publications
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the presence of
abnormal α-synuclein (αS) deposits in the brain. Alterations in homeostasis and metal …
abnormal α-synuclein (αS) deposits in the brain. Alterations in homeostasis and metal …
Review of Amyotrophic Lateral Sclerosis, Parkinson's and Alzheimer's diseases helps further define pathology of the novel paradigm for Alzheimer's with heavy metals …
F Cavaleri - Medical hypotheses, 2015 - Elsevier
Pathologies of neurological diseases are increasingly recognized to have common
structural and molecular events that can fit, sometimes loosely, into a central pathological …
structural and molecular events that can fit, sometimes loosely, into a central pathological …